Controlled release encapsulated antibiotic for the treatment of chronic infectious diseases /
Doaa Hussein Mobarak
Controlled release encapsulated antibiotic for the treatment of chronic infectious diseases / حويصلات محكمة الانطلاق لاحد مضادات البكتريا لعلاج الالتهاب المزمنة Doaa Hussein Mobarak ; Supervised Seham A. Elkheshen , Salwa Salah Eldin - Cairo : Doaa Hussein Mobarak , 2012 - 183 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic osteomyelitis is a challenging disease and very expensive to treat besides being recurrent. Chronic osteomyelitis recurrence is now highly suggested to be related to the intracellular infection caused by the staphylococcus aureus (S.A.). Nanoparticles (NPs) offer several advantages. Ciprofloxacin (CP) is a second generation fluroquinolone antibiotic with a broad spectrum against both gram positive and gram negative bacteria
Ciprofloxacin hydrochloride Microbiological evaluation Nanoparticles
Controlled release encapsulated antibiotic for the treatment of chronic infectious diseases / حويصلات محكمة الانطلاق لاحد مضادات البكتريا لعلاج الالتهاب المزمنة Doaa Hussein Mobarak ; Supervised Seham A. Elkheshen , Salwa Salah Eldin - Cairo : Doaa Hussein Mobarak , 2012 - 183 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic osteomyelitis is a challenging disease and very expensive to treat besides being recurrent. Chronic osteomyelitis recurrence is now highly suggested to be related to the intracellular infection caused by the staphylococcus aureus (S.A.). Nanoparticles (NPs) offer several advantages. Ciprofloxacin (CP) is a second generation fluroquinolone antibiotic with a broad spectrum against both gram positive and gram negative bacteria
Ciprofloxacin hydrochloride Microbiological evaluation Nanoparticles